Insights
Plain-English breakdowns of the warning letters, settlements, and regulatory shifts that determine whether your marketing can survive contact with a regulator.
Page 2 of 9
Instagram and TikTok overlay platform policies on top of FDA and FTC rules, and both platforms have tightened healthcare advertising substantially in 2024–2025. This post covers the interaction, the highest-risk patterns, and a 15-minute pre-launch checklist every ad should pass.
Dental marketing looks safer than regenerative medicine at first glance, but longevity guarantees, cosmetic-outcome promises, and pain-free-procedure language make dental practices a repeat target for FTC and state dental board enforcement. This post is the dental-specific rulebook.
One Instagram post. Five claims about stem cells. $5.15M paid and a 20-year compliance leash. The case that sets the current FTC enforcement bar for every healthcare practice - and the specific mistakes you can avoid by reading it carefully.
The FDA has issued hundreds of warning letters to stem cell, exosome, and PRP clinics since 2017. Here's a full breakdown of what the campaign covers, the exact claim categories CBER cites, and the compliance playbook that keeps practices out of the enforcement pipeline.
A 1997 FTC consent order set the template for how weight-loss testimonials must be disclosed. It is still the standard in 2026 - and most GLP-1 clinics, med spas, and telehealth weight-loss practices are marketing in direct violation of it without realizing it.
Every time you say 'clinically proven,' 'scientifically backed,' or 'evidence-based,' the FTC expects you to have something specific on file. Here's what the POM Wonderful precedent actually requires - and why most practices don't meet the bar.
Every med spa ad saying 'Botox by Nurse Smith' or 'Juvederm specials this month' is operating under rules most clinics don't know exist. Here's the full playbook for brand-name neurotoxin and filler advertising compliance.
'Get Ozempic for weight loss' is one of the most common weight-loss clinic ads in 2026. It is also one of the clearest FDA prescription-drug advertising violations. Here's the full compliance framework for GLP-1 brand marketing.
Most aesthetic practices use 'FDA-approved' to describe devices that are technically FDA-cleared. The distinction matters - FDA warning letters regularly cite it. Here's the complete breakdown of the three statuses and which one applies to your equipment.
Stay ahead of enforcement
RegenCompliance checks every word of your clinic's marketing against live FDA and FTC enforcement data - and rewrites violations automatically.